PRO-ACTIVE
Recruiting
850 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
MOMENTUM
Recruiting
8,000 enrolled
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Withdrawn
QVA-Mod
Not yet recruiting
180 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Enrolling by invitation
25 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
PDR-CARE
Recruiting
200 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
PTC-IMPACT
Recruiting
50 enrolled
IMPACT
Active not recruiting
3,026 enrolled
IMPLICATION
Completed
167 enrolled
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
Recruiting
200 enrolled
UNC Pleural Fluid Registry
Recruiting
9,999 enrolled
OvAR-Y
Recruiting
10 enrolled
TraveraRTGx
Recruiting
200 enrolled
SBRT
Completed
98 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Recruiting
470 enrolled
C-MOT
Recruiting
2,400 enrolled
K-ACCELERATE
Enrolling by invitation
1,000 enrolled
PRIORITY
Completed
346 enrolled 9 charts
START
Terminated
10 enrolled
Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing
Recruiting
55 enrolled
Defining Musical Toxicity and Its Effect on Patient Well-being
Withdrawn
Cytological Examination of Malignant Pleural Effusion in Breast Cancer
Completed
50 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
Integrin αvβ6-targeted PET in Malignant Tumors
Recruiting
200 enrolled
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Completed
300 enrolled
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Withdrawn
PREFER
Completed
1,429 enrolled
INSPIRE
Recruiting
5,350 enrolled
K-DETEK
Completed
9,057 enrolled
BEGIN
Recruiting
400 enrolled
SOMEST'ALIM2
Not yet recruiting
96 enrolled
MOHCCN-O
Recruiting
500 enrolled
Improving Evidence-Based Care for Cancer Patients
Completed
128 enrolled
OCTANE
Recruiting
10,000 enrolled
VCV
Not yet recruiting
515 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
The Impact of Radiotherapy on Oligometastatic Cancer
Recruiting
2,000 enrolled